BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15141382)

  • 1. Co-expression of neuregulins 1, 2, 3 and 4 in human breast cancer.
    Dunn M; Sinha P; Campbell R; Blackburn E; Levinson N; Rampaul R; Bates T; Humphreys S; Gullick WJ
    J Pathol; 2004 Jun; 203(2):672-80. PubMed ID: 15141382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuregulins 1-4 are expressed in the cytoplasm or nuclei of ductal carcinoma (in situ) of the human breast.
    Marshall C; Blackburn E; Clark M; Humphreys S; Gullick WJ
    Breast Cancer Res Treat; 2006 Mar; 96(2):163-8. PubMed ID: 16261396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosis.
    Révillion F; Lhotellier V; Hornez L; Bonneterre J; Peyrat JP
    Ann Oncol; 2008 Jan; 19(1):73-80. PubMed ID: 17962208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A recurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin/NRG1 gene.
    Adélaïde J; Huang HE; Murati A; Alsop AE; Orsetti B; Mozziconacci MJ; Popovici C; Ginestier C; Letessier A; Basset C; Courtay-Cahen C; Jacquemier J; Theillet C; Birnbaum D; Edwards PA; Chaffanet M
    Genes Chromosomes Cancer; 2003 Aug; 37(4):333-45. PubMed ID: 12800145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of novel spliced variants of neuregulin 4 in prostate cancer.
    Hayes NV; Blackburn E; Smart LV; Boyle MM; Russell GA; Frost TM; Morgan BJ; Baines AJ; Gullick WJ
    Clin Cancer Res; 2007 Jun; 13(11):3147-55. PubMed ID: 17545517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of sigma 1 receptor in human breast cancer.
    Wang B; Rouzier R; Albarracin CT; Sahin A; Wagner P; Yang Y; Smith TL; Meric-Bernstam F; Marcelo Aldaz C; Hortobagyi GN; Pusztai L
    Breast Cancer Res Treat; 2004 Oct; 87(3):205-14. PubMed ID: 15528963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma.
    Oue N; Mitani Y; Aung PP; Sakakura C; Takeshima Y; Kaneko M; Noguchi T; Nakayama H; Yasui W
    J Pathol; 2005 Oct; 207(2):185-98. PubMed ID: 16086444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a neural-specific splicing form of the human neuregulin 3 gene involved in oligodendrocyte survival.
    Carteron C; Ferrer-Montiel A; Cabedo H
    J Cell Sci; 2006 Mar; 119(Pt 5):898-909. PubMed ID: 16478787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
    Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
    Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients: a novel model for tumor progression.
    Davidson B; Konstantinovsky S; Nielsen S; Dong HP; Berner A; Vyberg M; Reich R
    Clin Cancer Res; 2004 Nov; 10(21):7335-46. PubMed ID: 15534110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
    Benhaj K; Akcali KC; Ozturk M
    Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-erbB-2 mRNA in breast cancer specimens that exhibit membrane or cytoplasmic immunoreactivity for c-erbB-2.
    Taylor SL; Rudland PS; Barraclough R
    Oncol Res; 1999; 11(7):311-7. PubMed ID: 10757445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of ZER6 in ERalpha-positive breast cancer.
    Stabach PR; Thiyagarajan MM; Weigel RJ
    J Surg Res; 2005 Jun; 126(1):86-91; discussion 1-2. PubMed ID: 15916980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokeratin expression in malignant melanoma: potential application of in-situ hybridization analysis of mRNA.
    Chen N; Gong J; Chen X; Xu M; Huang Y; Wang L; Geng N; Zhou Q
    Melanoma Res; 2009 Apr; 19(2):87-93. PubMed ID: 19190520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression and pathological significance of autocrine motility factor/glucose-6-phosphate isomerase expression in human lung carcinomas.
    Dobashi Y; Watanabe H; Sato Y; Hirashima S; Yanagawa T; Matsubara H; Ooi A
    J Pathol; 2006 Dec; 210(4):431-40. PubMed ID: 17029220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression.
    Schubert A; Schulz H; Emons G; Gründker C
    Gynecol Endocrinol; 2008 Jun; 24(6):331-8. PubMed ID: 18584413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
    Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
    Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of estrogen receptor alpha and beta and progesterone receptor expression and correlation with clinicopathologic factors and proliferative marker Ki-67 in breast cancers.
    Rosa FE; Caldeira JR; Felipes J; Bertonha FB; Quevedo FC; Domingues MA; Moraes Neto FA; Rogatto SR
    Hum Pathol; 2008 May; 39(5):720-30. PubMed ID: 18234277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.